Randomized clinical trial of surgical vs. percutaneous vs. hybrid revascularization in multivessel coronary artery disease: residual myocardial ischemia and clinical …
V Ganyukov, N Kochergin, A Shilov… - Journal of …, 2020 - Wiley Online Library
Aim. Optimal revascularization strategy in multivessel (MV) coronary artery disease (CAD)
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
[PDF][PDF] Clinical Study Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual …
V Ganyukov, N Kochergin, A Shilov, R Tarasov… - 2020 - core.ac.uk
Aim. Optimal revascularization strategy in multivessel (MV) coronary artery disease (CAD)
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia and …
V Ganyukov, N Kochergin, A Shilov… - Journal of …, 2020 - go.gale.com
Aim. Optimal revascularization strategy in multivessel (MV) coronary artery disease (CAD)
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
[HTML][HTML] Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia …
V Ganyukov, N Kochergin, A Shilov… - Journal of …, 2020 - ncbi.nlm.nih.gov
Aim Optimal revascularization strategy in multivessel (MV) coronary artery disease (CAD)
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia and …
V Ganyukov, N Kochergin, A Shilov, R Tarasov… - 2020 - pubmed.ncbi.nlm.nih.gov
Aim Optimal revascularization strategy in multivessel (MV) coronary artery disease (CAD)
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
[HTML][HTML] Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia …
V Ganyukov, N Kochergin, A Shilov… - Journal of …, 2020 - search.proquest.com
Aim. Optimal revascularization strategy in multivessel (MV) coronary artery disease (CAD)
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia and …
V Ganyukov, N Kochergin, A Shilov, R Tarasov… - Journal of …, 2020 - elibrary.ru
Aim. Optimal revascularization strategy in multivessel (MV) coronary artery disease (CAD)
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
[PDF][PDF] Randomized clinical trial of surgical vs. percutaneous vs. hybrid revascularization in multivessel coronary artery disease: residual myocardial ischemia and …
V Ganyukov, N Kochergin, A Shilov… - Journal of …, 2020 - ruj.uj.edu.pl
Aim. Optimal revascularization strategy in multivessel (MV) coronary artery disease (CAD)
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia and …
V Ganyukov, N Kochergin, A Shilov… - Journal of …, 2020 - europepmc.org
Aim Optimal revascularization strategy in multivessel (MV) coronary artery disease (CAD)
eligible for percutaneous management (PCI) and surgery remains unresolved. We …
eligible for percutaneous management (PCI) and surgery remains unresolved. We …